Transfer of high cost drugs to NICE risks fragmentation of care of rare diseases

Transfer of high cost drugs to NICE risks fragmentation of care of rare diseases

In an ongoing strategy to raise the profile of the Secretary of State for Health, through the Health and Social Care Act 2012, plans to abolish AGNSS and transfer the commissioning of the LSD service to the NHS Commissioning Board. Clinicians from the LSD national treatment centres and patient representatives submitted an article to the British Journal of Medicine (BMJ); see the link below to view the article or dowload the PDF;